Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ANGO holding history

Angiodynamics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ANGO overviewAll 13F holders of ANGOFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of ANGO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−23,143−100.0%Sold outHolders
Q4 202523,143$297.2K<0.1%+3,602+18.4%AddedHolders
Q3 202519,541$218.3K<0.1%−45,801−70.1%ReducedHolders
Q2 202565,342$648.2K<0.1%−165,564−71.7%ReducedHolders
Q1 2025230,906$2.17M<0.1%−16,168−6.5%ReducedHolders
Q4 2024247,074$2.26M<0.1%+28,493+13.0%AddedHolders
Q3 2024218,581$1.70M<0.1%−98,171−31.0%ReducedHolders
Q2 2024316,752$1.92M<0.1%−257,408−44.8%ReducedHolders
Q1 2024574,160$3.37M<0.1%−30,291−5.0%ReducedHolders
Q4 2023604,451$4.74M<0.1%−81,548−11.9%ReducedHolders
Q3 2023685,999$5.01M<0.1%+291,210+73.8%AddedHolders
Q2 2023394,789$4.12M<0.1%+148,373+60.2%AddedHolders
Q1 2023246,416$2.55M<0.1%+46,509+23.3%AddedHolders
Q4 2022199,907$2.75M<0.1%+199,907NewHolders
Q3 20220$00.0%−23,327−100.0%Sold outHolders
Q2 202223,327$451.0K<0.1%−1,123−4.6%ReducedHolders
Q1 202224,450$527.0K<0.1%−27,603−53.0%ReducedHolders
Q4 202152,053$1.44M<0.1%−44,344−46.0%ReducedHolders
Q3 202196,397$2.50M<0.1%−24,324−20.1%ReducedHolders
Q2 2021120,721$3.27M<0.1%−77,227−39.0%ReducedHolders
Q1 2021197,948$4.63M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.